Myopia Control in European Children - Study Protocol and Methodology

Autoři

KOMÍNEK Martin AUTRATA Rudolf KREJČÍŘOVÁ Inka ŽAJDLÍKOVÁ Barbora HEISSIGEROVÁ J. KORBASOVÁ M. STUDENÝ P. DOSTÁLEK M. HLOŽÁNEK M. UNAR VINKLEROVÁ Jana

Rok publikování 2022
Druh Článek v odborném periodiku
Časopis / Zdroj HSOA Journal of Neonatology and Clinical Pediatrics
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www MARS
Doi http://dx.doi.org/10.24966/NCP-878X/100096
Klíčová slova Atropine eye drops; Axial length of eye; Low dose atropine; Myopia in children; Progressive myopia
Popis Purpose To report study protocol and methodology of multicentre, Randomized, double-blind, placebo-controlled study of the efficacy and safety of low dose atropine eye drops (0.02%, 0.04%) in slowing the progression of short-sightedness (myopia) in children. M.A.R.S. (Myopia and Atropin ReStriction). Conclusion M.A.R.S. clinical trial will enrich the knowledge about myopia and its possible treatment in the early stages in European children. It will be beneficial for paediatric patients, practicing paediatricians and ophthalmologist. In the future it will be helpful not only from a medical point of view, but also in economic aspect of management of progression of myopia in children and all the entire population.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info